Gall Matthew Insider Trades

Insider Trading History

Track insider trading activity for Gall Matthew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tango Therapeutics
Tango Therapeutics TNGX
Chief Financial Officer
Holding Value $5.15M 240,000 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.87M 280,000 shares
$20.98
$21.47
Kalaris Therapeutics
Kalaris Therapeutics KLRS
Chief Financial Officer
Holding Value $448k 95,000 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 95,000 shares
$6.81
$4.72
Kalaris Therapeutics
Kalaris Therapeutics KLRS
Chief Financial Officer
Holding Value $1.11M 235,000 shares
Last Trade
Nov 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 235,000 shares
$4.99
$4.72
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Aug 29, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$899k 89,429 shares
$10.05
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Aug 29, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.94M 388,072 shares
$10.15
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $1.47M 145,000 shares
Last Trade
Mar 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 145,000 shares
$7.05
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $664k 65,429 shares
Last Trade
Nov 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.7k 5,000 shares
$7.73
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $1.66M 163,200 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89M 163,200 shares
$11.58
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $613k 60,429 shares
Last Trade
Dec 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 41,000 shares
$9.84
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $197k 19,429 shares
Last Trade
Oct 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$41.9k 5,000 shares
$8.37
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $1.32M 130,000 shares
Last Trade
Mar 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.17M 130,000 shares
$16.66
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $863k 85,000 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.05M 85,000 shares
$35.86
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $146k 14,429 shares
Last Trade
Dec 27, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$232k 5,000 shares
$46.45
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $197k 19,429 shares
Last Trade
Oct 11, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$387k 14,429 shares
$26.83
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $430k 42,388 shares
Last Trade
Oct 11, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$387k 14,429 shares
$26.83
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $244k 24,000 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 24,000 shares
$23.19
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $50.8k 5,000 shares
Last Trade
Jun 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$130k 5,000 shares
$26.09
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $731k 72,000 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.99M 72,000 shares
$41.58
$10.15
ITeos Therapeutics
ITeos Therapeutics ITOS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 23, 2020 Sale
No data
No data
$10.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up